5J8-26380-82625 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-09-29
Dose 1 — Pfizer-BioNTech
2022-11-10
Dose 2 — Pfizer-BioNTech
2022-12-14
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-12-28
Registered in v-safe
2022-12-29
Survey response — day 14, dose 3, under 3
MedDRA: COVID-19, Cough — Feeling: Poor · Be unable to work or attend school

Free text: COVID positive and a cough

MedDRA releases: 2024-11 · check-in free text available
2023-01-06
Health check-in — day 21, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-01-20
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-01-25
Survey response — day 42, dose 3, under 3
MedDRA: Cough, Respiratory tract congestion — Feeling: Fair

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-09-29	Pfizer-BioNTech	No
2	2022-11-10	Pfizer-BioNTech	No
3	2022-12-14	Pfizer-BioNTech	Flu

Free text

Release 12 (Under 3) — day 14, dose 3, under 3

2022-12-29

Symptoms: COVID positive and a cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release